These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23749691

  • 1. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
    Sands D.
    Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
    [Abstract] [Full Text] [Related]

  • 2. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A.
    BMC Pediatr; 2006 Oct 03; 6():25. PubMed ID: 17018149
    [Abstract] [Full Text] [Related]

  • 3. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
    Ooi CY, Dupuis A, Gonska T, Ellis L, Ni A, Jarvi K, Martin S, Ray P, Steele L, Kortan P, Dorfman R, Solomon M, Zielenski J, Corey M, Tullis E, Durie P.
    Ann Am Thorac Soc; 2014 May 03; 11(4):562-70. PubMed ID: 24697796
    [Abstract] [Full Text] [Related]

  • 4. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR, Paradiso AM, Boucher RC.
    Hum Gene Ther; 1995 Apr 03; 6(4):445-55. PubMed ID: 7542031
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
    Middleton PG, Geddes DM, Alton EW.
    Eur Respir J; 1994 Nov 03; 7(11):2050-6. PubMed ID: 7875281
    [Abstract] [Full Text] [Related]

  • 8. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.
    Sermet-Gaudelus I, Girodon E, Sands D, Stremmler N, Vavrova V, Deneuville E, Reix P, Bui S, Huet F, Lebourgeois M, Munck A, Iron A, Skalicka V, Bienvenu T, Roussel D, Lenoir G, Bellon G, Sarles J, Macek M, Roussey M, Fajac I, Edelman A.
    Am J Respir Crit Care Med; 2010 Oct 01; 182(7):929-36. PubMed ID: 20538955
    [Abstract] [Full Text] [Related]

  • 9. Nasal potential difference in congenital bilateral absence of the vas deferens.
    Pradal U, Castellani C, Delmarco A, Mastella G.
    Am J Respir Crit Care Med; 1998 Sep 01; 158(3):896-901. PubMed ID: 9731023
    [Abstract] [Full Text] [Related]

  • 10. Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.
    Tridello G, Menin L, Pintani E, Bergamini G, Assael BM, Melotti P.
    J Cyst Fibros; 2016 Sep 01; 15(5):579-82. PubMed ID: 27423539
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium.
    Rückes-Nilges C, Lindemann H, Klimek T, Glanz H, Weber WM.
    Pflugers Arch; 2000 Nov 01; 441(1):133-7. PubMed ID: 11205052
    [Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
    Mainz J, Hammer U, Rokahr C, Hubler A, Zintl F, Ballmann M.
    Respiration; 2006 Nov 01; 73(5):698-704. PubMed ID: 16763370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
    Ostrowski LE, Yin W, Diggs PS, Rogers TD, O'Neal WK, Grubb BR.
    Gene Ther; 2007 Oct 01; 14(20):1492-501. PubMed ID: 17637798
    [Abstract] [Full Text] [Related]

  • 15. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M, Bleich M, Greger R, Schreiber R, Kunzelmann K.
    J Clin Invest; 1998 Jul 01; 102(1):15-21. PubMed ID: 9649552
    [Abstract] [Full Text] [Related]

  • 16. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis.
    Lubamba B, Lecourt H, Lebacq J, Lebecque P, De Jonge H, Wallemacq P, Leal T.
    Am J Respir Crit Care Med; 2008 Mar 01; 177(5):506-15. PubMed ID: 18006891
    [Abstract] [Full Text] [Related]

  • 17. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
    Middleton PG, House HH.
    Pediatr Pulmonol; 2010 Aug 01; 45(8):789-95. PubMed ID: 20597077
    [Abstract] [Full Text] [Related]

  • 18. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
    Sermet-Gaudelus I, Déchaux M, Vallée B, Fajac A, Girodon E, Nguyen-Khoa T, Marianovski R, Hurbain I, Bresson JL, Lenoir G, Edelman A.
    Am J Respir Crit Care Med; 2005 May 01; 171(9):1026-31. PubMed ID: 15709055
    [Abstract] [Full Text] [Related]

  • 19. Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey.
    Naehrlich L, Ballmann M, Davies J, Derichs N, Gonska T, Hjelte L, van Konigsbruggen-Rietschel S, Leal T, Melotti P, Middleton P, Tümmler B, Vermeulen F, Wilschanski M, ECFS Diagnostic Network Working Group.
    J Cyst Fibros; 2014 Jan 01; 13(1):24-8. PubMed ID: 24022019
    [Abstract] [Full Text] [Related]

  • 20. The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis.
    Davies MG, Geddes DM, Alton EW.
    Am J Respir Crit Care Med; 2005 Apr 01; 171(7):760-3. PubMed ID: 15618459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.